Aptagen, LLC
RNA
Periostin
Protein
1.07 nM (reported value)
40 mM/1 HEPES, 102 mM/1 NaCl, 5 mM/1mol/1g Cl2,5 mM KCl
37°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5' benzylaminocarbonyl-d U modification
Periostin Aptamer (PNDA-3) (ID# 530)
154
15666.2 g/mole
483400 L/(mole·cm)
52.94%
2.07
32.41
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Lee, Y., Kim, I., Park, S., Kim, Y., Wu, S., Lee, J., Noh, D., Kim, K., Ryu, S. and Suh, P. "Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis." The American Society of Gene & Cell Therapy 21.5 (2013): 1004-13.
Have your aptamer oligo synthesized ORDER NOW
We are always looking for ways to improve. Please tell us what you think.